JUL 21, 2020 11:42 AM PDT

Investigating New Anti-Blood Clotting Treatments

WRITTEN BY: Jasper Cantrell

When it comes to your cardiovascular health, it is important to look at more than just your heart. The cardiovascular system could be summarized as a pathway for your blood to run through your body. Any issues with the proper flow of blood can cause major damage to the body. These issues can be things such as heart dysfunction, obstruction of a blood vessel, or (the scariest, in my opinion) blood clots.

Blood clots form when there is an injury to the blood vessels. The body responds by combining platelets with fibrin at the wound, where they coagulate and prevent blood loss. However, abnormal blood clots can block blood flow and cause tissue damage. 

Several things can be done to prevent blood clots, from exercising to a healthy diet, but some factors are out of your control. Scientists have sought to identify any biomarkers against the risk of blood clots and have found a few with promise.

The Von Willebrand factor (VWF) is one such biomarker.  It is a small protein involved in the initial blood clot formation caused by high shearing forces. These shearing forces are usually due to high blood flow surrounding clogged arteries. It is already considered a poor prognostic indicator for cardiovascular health, and anti-VWF drugs have some promise for blood clot treatment and prevention. 

A team from the Medical University of Vienna in Austria sought to test a new anti-VWF drug, BT200. They set up blood clotting experiments using endotoxin (the toxic part of bacteria) and desmopressin (a kidney drug) to activate VWF. They would then treat the blood with BT200 and observe how it affected VWF activity.

BT200 treatment managed to inhibit VWF activation in all cases. The most significant find was that effective BT200 dosage was tied to VWF levels. This gives critical dosage information for future studies, and retroactive analysis showed that this characteristic was shared amongst all VWF inhibitors. Conventional clotting inhibitors usually do not catch VWF dependent clotting, so more research is needed into this treatment pathway.

The team concludes, “Even under conditions of stimulated VWF release, BT200 potently inhibits VWF activity and VWF-dependent platelet function. This is in contrast to conventional platelet inhibitors whose effects are compromised by elevated VWF under high shear rates.”

Sources: Nature Scientific Reports, LearnBlood

About the Author
  • Hey everyone! My name is Jasper and, considering I am pretty new here to Labroots, I figured I would introduce myself. I received my bachelor’s from the University of California at Riverside back in 2016. I started off my career a few years ago with a job at a University over in New York, before moving over into the industry. I'm happy to be writing content for Labroots, and I hope you enjoy it!
You May Also Like
APR 18, 2020
Cardiology
Is Good Sleep Necessary for a Healthy Heart?
APR 18, 2020
Is Good Sleep Necessary for a Healthy Heart?
Over 50 million Americans reportedly have trouble sleeping. As research is increasingly finding that having a good night ...
JUN 14, 2020
Chemistry & Physics
Why Are There So Few Black People in STEM?
JUN 14, 2020
Why Are There So Few Black People in STEM?
On June 10th, 2020, thousands of STEM scientists and organizations around the world went on strike to protest systemic r ...
JUL 02, 2020
Cardiology
Managing the Mitochondria After a Heart Attack
JUL 02, 2020
Managing the Mitochondria After a Heart Attack
Heart attacks are an unfortunately common occurrence across the country. One of the biggest consequences of a heart atta ...
JUL 14, 2020
Cardiology
Changing Your Doctor Can Cause Confusion in Your Chart
JUL 14, 2020
Changing Your Doctor Can Cause Confusion in Your Chart
Nowadays, many people’s lifestyle sees them move on to better pastures every few years. Staying in one place is no ...
JUL 28, 2020
Cancer
Should you get your DNA test for community-based genetic screening?
JUL 28, 2020
Should you get your DNA test for community-based genetic screening?
In a new study published in the journal Nature Medicine, researchers champion the potential of community-based gene ...
AUG 20, 2020
Cardiology
Cilia are Found to Have Vesicles That May Influence Heart Disease
AUG 20, 2020
Cilia are Found to Have Vesicles That May Influence Heart Disease
Cells have many specialized organelles, including a kind of signaling hub called a cilium, which sticks out of the surfa ...
Loading Comments...